<DOC>
	<DOCNO>NCT02703194</DOCNO>
	<brief_summary>The study design 12-month , open-label , randomize , control study compare use prednisone mono-therapy prednisone leflunomide combination therapy treat patient IgG4-related disease .</brief_summary>
	<brief_title>Leflunomide Maintenance Remission IgG4 Related Disease</brief_title>
	<detailed_description>The aim clinical trial determine safety efficacy Leflunomide treat patient IgG4-related disease compare outcome prednisone leflunomide combination therapy prednisone mono-therapy . The follow-up period 12 month . During follow-up period , result laboratory test image examination , IgG4-RD RI parameter reflect treatment response well adverse effect event record .</detailed_description>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Leflunomide</mesh_term>
	<mesh_term>Immunoglobulin G</mesh_term>
	<criteria>1 . Age 18 80 year . 2 . Diagnosis IgG4RD accord either Consensus statement pathology IgG4related disease ( undergone biopsy ) 2011 Comprehensive diagnostic criterion IgG4related disease . Both two criterion diagnosis specify . ( 1 ) Consensus statement pathology IgG4related disease 1 . Histopathologic feature consist dense lymphoplasmacytic infiltrate , fibrosis ( usually storiform character ) and/or obliterative phlebitis within involved organ . 2 . Either elevate IgG4+/IgG+cell ratio ＞40 % within affected organ elevate IgG4bearing plasma cell per highpower field necessary . The cutoff number IgG4bearing plasma cell per highpower field different depend upon type affected organ specimen ( surgery needle puncture biopsy ) . ( 2 ) 2011 Comprehensive diagnostic criterion IgG4related disease 1 . Clinical examination show characteristic diffuse/localized swelling mass single multiple organ . 2 . Hematological examination show elevate serum IgG4 concentration ( 135 mg/dl ) . 3 . Histopathologic examination show mark lymphocyte plasmacyte infiltration fibrosis Infiltration IgG4+ plasma cell ( ratio IgG4+/IgG+ cell &gt; 40 % &gt; 10 IgG4+ plasma cells/HPF ) . Definite : + b + c , Probable : + c , Possible : + b 4 . Excluded malignant tumor organ ( e.g . cancer , lymphoma ) similar disease ( e.g . Sjögren 's syndrome , primary sclerosing cholangitis , Castleman 's disease , secondary retroperitoneal fibrosis , Wegener 's granulomatosis , sarcoidosis , ChurgStrauss syndrome ) additional histopathological examination . 5 . Even patient diagnose use Comprehensive diagnostic criterion , may diagnose use organspecific diagnostic criterion IgG4RD , Diagnostic criteria IgG4Mikulicz 's disease . 1 . Subjects receive steroids immunosuppressant recent 3 month exclude . 2 . Subjects hypersensitive leflunomide exclude . 3 . ALT and/or AST two fold upper limit relevant reference value baseline . 4 . WBC le 3×10*9/L baseline . 5 . Female patient pregnant breastfeeding . 6 . Known significant concurrent medical disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>IgG4-related disease</keyword>
	<keyword>IgG4-related sclerosing cholangitis</keyword>
	<keyword>Mikulicz disease</keyword>
	<keyword>Pancreatitis</keyword>
	<keyword>Retroperitoneal fibrosis</keyword>
	<keyword>Lymphadenopathy</keyword>
</DOC>